SPRO - Spero Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5199.25M
Enterprise Value 3114.71M
Trailing P/E N/A
Forward P/E 1-3.19
PEG Ratio (5 yr expected) 1-0.15
Price/Sales (ttm)18.92
Price/Book (mrq)1.74
Enterprise Value/Revenue 310.89
Enterprise Value/EBITDA 6-3.09

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-357.86%

Management Effectiveness

Return on Assets (ttm)-22.90%
Return on Equity (ttm)-38.35%

Income Statement

Revenue (ttm)10.53M
Revenue Per Share (ttm)0.63
Quarterly Revenue Growth (yoy)569.40%
Gross Profit (ttm)-29.92M
EBITDA -37.19M
Net Income Avi to Common (ttm)-36.09M
Diluted EPS (ttm)-2.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)106.39M
Total Cash Per Share (mrq)6.07
Total Debt (mrq)5.03M
Total Debt/Equity (mrq)4.44
Current Ratio (mrq)17.48
Book Value Per Share (mrq)6.52

Cash Flow Statement

Operating Cash Flow (ttm)-38.59M
Levered Free Cash Flow (ttm)-27.32M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 35.07%
S&P500 52-Week Change 34.92%
52 Week High 318.23
52 Week Low 35.52
50-Day Moving Average 312.24
200-Day Moving Average 310.17

Share Statistics

Avg Vol (3 month) 380.72k
Avg Vol (10 day) 364.79k
Shares Outstanding 517.52M
Float 10.27M
% Held by Insiders 123.71%
% Held by Institutions 153.59%
Shares Short (Apr 30, 2019) 4273.54k
Short Ratio (Apr 30, 2019) 43.68
Short % of Float (Apr 30, 2019) 42.14%
Short % of Shares Outstanding (Apr 30, 2019) 41.57%
Shares Short (prior month Mar 29, 2019) 4237.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A